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Summary
Dental pulp is particularly interesting in regenerative medicine because of the accessibility and differentiation potential of the tissue.
Dental pulp has an early developmental origin with multi-lineage differentiation potential as a result of its development during
childhood and adolescence. However, no study has previously identified the presence of stem cell populations with embryonic-like
phenotypes in human dental pulp from the third molar. In the present work, we describe a new population of dental pulp pluripotent-like
stem cells (DPPSCs) that were isolated by culture in medium containing LIF, EGF and PDGF. These cells are SSEA4+, OCT3/4+,
NANOG+, SOX2+, LIN28+, CD13+, CD105+, CD342, CD452, CD90+, CD29+, CD73+, STRO1+ and CD1462, and they show genetic
stability in vitro based on genomic analysis with a newly described CGH technique. Interestingly, DPPSCs were able to form both
embryoid-body-like structures (EBs) in vitro and teratoma-like structures that contained tissues derived from all three embryonic germ
layers when injected in nude mice. We examined the capacity of DPPSCs to differentiate in vitro into tissues that have similar
characteristics to mesoderm, endoderm and ectoderm layers in both 2D and 3D cultures. We performed a comparative RT-PCR analysis
of GATA4, GATA6, MIXL1, NANOG, OCT3/4, SOX1 and SOX2 to determine the degree of similarity between DPPSCs, EBs and human
induced pluripotent stem cells (hIPSCs). Our analysis revealed that DPPSCs, hIPSC and EBs have the same gene expression profile.
Because DPPSCs can be derived from healthy human molars from patients of different sexes and ages, they represent an easily
accessible source of stem cells, which opens a range of new possibilities for regenerative medicine.
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Introduction
Stem cells have the ability to self-renew and to generate mature,
differentiated cells (Fuchs and Segre, 2000). The main postnatal
function of stem cells is to repair and regenerate the tissues in
which they reside. As pluripotent stem cells have become a major
focus of scientific research, many techniques have been developed
to determine the actual pluripotency of embryonic stem (ES) cells
or induced pluripotent stem (iPS) cells. The pluripotency of human
stem cells can be tested in two different ways: teratoma formation
by cells injected subcutaneously and the aggregation and
generation of embryoid bodies (EBs) from cells cultured in vitro
(O’Connor et al., 2008; Papapetrou et al., 2009). These techniques
demonstrate a multilineage differentiation capability by which
stem cells can give rise to cells of all three germ layers (Itskovitz-
Eldor et al., 2000; Martin and Evans, 1975).
Dental pulp tissue is thought to be derived from migratory
neural crest cells during development (Peters and Balling, 1999;
Thesleff and Aberg, 1999), and it has been shown to harbour
various populations of multipotent stem/progenitor cells (Miura
et al., 2003; Nosrat et al., 2001). To date, multiple human dental
stem/progenitor cells have been isolated, characterised, and
classified as a group designated ‘dental pulp stem cells’
(DPSCs). These include stem cells from exfoliated deciduous
teeth (SHEDs), periodontal ligament stem cells (PDLSCs), dental
follicle progenitor cells (DFPCs) and stem cells from apical papilla
(SCAPs). These post-natal populations have mesenchymal stem
cell (MSC)-like qualities, namely the capacity for self-renewal,
the potential to differentiate into multiple lineages, including
osteoblasts and chondroblasts, and a potential for in vitro
differentiation into cell types from various embryonic layers,
including adipose, bone, endothelial and neural-like tissues
(Arthur et al., 2008; Cheng et al., 2008; Cordeiro et al., 2008;
Fujii et al., 2008; Gay et al., 2007; Harada et al., 1999; He et al.,
2009; Honda et al., 2008; Huo et al., 2010). Many researchers have
proposed that DPMSCs are promising candidates for the repair and
regeneration of a variety of mesenchymal tissues, such as bone,
cartilage and muscle (Dezawa et al., 2005; Noe¨l et al., 2002).
These findings, together with those of other studies, also suggest
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that cells from the dental pulp may represent a unique population
based on their regenerative potential (About et al., 2000; Gronthos
et al., 2000; Iohara et al., 2004; Mina and Braut, 2004; Zhang et al.,
2005). However, no optimal culture medium that allows adult stem
cell amplification without self-differentiation has yet been reported
(d’Aquino et al., 2007; Stevens et al., 2008).
No previous study to date has described the presence and
isolation of human dental pulp stem cells with pluripotent-like
characteristics at a single-cell level, nor the use of culture media
containing LIF (leukaemia inhibitor factor), EGF (epidermal
growth factor) and PDGF (platelet derived growth factor) for
isolation of these cells. In the present study, we describe the
isolation and identification of a subpopulation of pluripotent-like
stem cells from the dental pulp of third molars (termed DPPSCs)
that show greater regenerative power than currently used
mesenchymal stem cells. These DPPSCs are SSEA4+, OCT4+,
NANOG+, SOX2+, LIN28+, CD13+, CD105+, CD342, CD452,
CD90+, CD29+, CD732, STRO1+ and CD1462. We investigated
the capacity of DPPSCs to differentiate in vitro into tissues that
have similar characteristics to embryonic mesoderm, endoderm
and ectoderm layers in 2D and 3D, as well as their ability to
generate EB-like structures and to develop teratoma-like
structures when injected into nude mice. We also performed a
comparative analysis of GATA4, GATA6, MIXL1, NANOG,
OCT3/4, SOX1 and SOX2 by RT-PCR to determine the degree
of similarity between DPPSCs, EBs and human iPS cells.
DPPSCs are derived from an easily accessible source, and they
can be used in future protocols for the regeneration of tissues
from the three embryonic layers.
Results
Characterisation and isolation of dental pulp pluripotent
stem cells
These studies were carried out with the goal of isolating and
purifying a population of pluripotent-like stem cells derived from
dental pulp (DPPSCs). We analysed the phenotypes of all
populations, each of which corresponds to a dental pulp donor,
cultivated at a density of 802100 cells per cm2 and expanded at
different passages when the cultures reached 60% confluence.
Colony formation was observed, especially when the cells were
cultured by the hanging drop method. When colonies were
seeded into adherent surfaces cells tended to migrate
(supplementary material Fig. S1). We performed FACS, qRT-
PCR, immunophenotype analysis and cytogenetic analysis.
(Fig. 1A) shows representative images of DPPSCs morphology
at P5, P10 and P15. DPPSCs are small-sized cells with large
nuclei and low cytoplasm content, without the typical flat and
elongated MSC appearance. The morphology of DPPSCs
cultured in a Cell Carrier 3D glass scaffold was also examined
using scanning electronic microscopy (supplementary material
Fig. S2). Immunofluorescence assays for SSEA4, OCT3/4 and
NANOG showed that cells were positive for all three markers and
that SSEA4 localised in the cytoplasm, whereas embryonic
transcription factors were located in the nucleus (Fig. 1B).
The development of therapeutic strategies depends on the
ability of stem cells to undergo large scale in vitro amplification,
which can be associated with genetic instability. 85% of
DPPSCs exhibited a normal karyotype with no presence of
any aneuploidy, polyploidy or any chromosome structural
abnormality in metaphases after more than 65 passages (Fig. 1C).
Using transmission electron microscopy (TEM), we evaluated
the morphology and integrity of the cells (Fig. 1D). A notable
feature of DPPSCs is that they possess large nuclei relative to
cytoplasm volume, which is also a characteristic of ES cells.
Short-CGH analysis demonstrates genetic stability of DPPSCs
as they showed the same genetic dose as a healthy control
sample. A gain in X and a loss of Y chromosome dose can be
seen, where this is due to sex differences: DPPSCs were extracted
from a female patient, whereas the cells onto which the
hybridisation was performed were from a male donor (Fig. 1E).
In order to further characterise the population, we analysed the
cells by flow cytometry and found that the population was
CD105+, CD146+, CD452, CD342, STRO1+, TRA1-602, OCT3/
4+ and NANOG2 (Fig. 2A,B). Double staining for OCT3/4 and
NANOG was also carried out showing a 19.55% of double
positive cells (Fig. 2C). Some differences in the expression level
were found between different passages. Interestingly, percentage
of SSEA4+, OCT3/4+ and NANOG+ increased with passages in
DPPSCs, whereas in DPMSCs, they remained negative
(supplementary material Table S2). We also looked for cells
expressing embryonic markers in pulp tissues from donors of
different ages on the day of extraction (supplementary material
Fig. S3). The percentage of SSEA4+ cells increased with age,
whereas the number of OCT3/4+ and CD13+ cells decreased with
age. In addition, we found that embryonic markers were still
expressed in DPPSCs from 58-year-old patients.
RNA was isolated from DPPSCs at P15, and expression of
OCT3/4, SOX2 and TERT was analysed by RT-PCR (Fig. 2D).
Western blot analysis of OCT3/4 expression was performed in
DPPSCs at P5, P10, P15 and P20. NTERA cells and bone marrow
multipotent adult progenitor cells (BM-MAPCs) were used as
positive controls, and Schwann cells and DPMSCs were used as
negative controls (Fig. 2E). Expression of OCT3/4 in DPPSCs
was maintained until at least P20.
The pluripotency of DPPSCs was assessed in vivo by teratoma
formation. The injection of DPPSCs (P15) into nude mice
resulted in the formation of teratoma-like structures that
contained tissues derived from all three embryonic germ layers.
DPPSCs from two different donors gave similar results. DPMSCs
from the same donors were used as negative controls, and did not
give rise to teratoma formation (Fig. 2F). We performed the
teratoma assays with four groups with a total number of seven 8-
week-old nude mice (Samtako Bio Korea, Seoul, Korea) were
anesthetized with diethyl ether. Group 1:2 mice injected with
cells from the 14-year-old donor. Group 2:2 mice injected
with cells from the 17-year-old donor. Group 3:2 mice
injected with cells from the 28-year-old donor. Group 4:1 mice
injected with Matrigel (BD). Four out of seven mice injected
developed teratoma-like forms with sizes of 0.6 to 1 cm just in
the left side, where DPPSCs were injected (two mice from group
1, and two from group 3). In contrast, when DPMSCs from the
same donor were injected, no teratoma formation was observed
(Fig. 2E). All the mice from group 2 died at 8 or 12 days after
injection. This result was unexpected and no obvious explanation
occurred to us.
Staining with H&E showed the formation of multiple adult
structures with origins in different embryonic layers (Fig. 2G;
supplementary material Fig. S4) such as chondroid tissue,
chondroid matrix, fibroblasts and collagen fibres, adipose tissue
and endothelium (Fig. 2L), gut-like epithelium (Fig. 2M), and
neural-like tissue such as nerve and keratin (Fig. 2N).
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Immunohistochemical staining was performed to evaluate the
expression of embryonic markers after 3 weeks (Fig. 2H–K).
Although DPPSCs expressed embryonic markers when they were
undifferentiated, expression of these genes was lost during
differentiation, and very few cells were positive for embryonic
markers at 3 weeks. Antihuman antibodies were used to confirm
that the tissues formed were of human origin.
The ability of DPPSCs to form EBs was studied using a micro-
patterned culture surface and centrifugal force (Fig. 3A). After 5
days of culture, the morphology of EBs was evaluated by light
microscopy (Fig. 3B). EBs exhibited the typical spherical and
well-limited appearance of EBs formed from ES cells. Alkaline
phosphatase (ALP) staining was performed to confirm the
stem-like properties of the EBs (Fig. 3C). Furthermore, the EBs
continued to express embryonic markers such as OCT3/4 and
NANOG at day 5, as observed by immunofluorescence
(Fig. 3D,E). The expression of embryonic markers and lineage
specific markers was studied by RT-PCR. The results showed
that DPPSCs and EBs from DPPSCs expressed embryonic
markers such as OCT3/4, NANOG and SOX2 as well as other
lineage markers as SOX1, BDNF, MIXL1, GATA4 and GATA6
with levels comparable to iPS cells. DPMSCs did not express
these markers (Fig. 3F). To confirm the results, a qRT-PCR was
performed to check the expression of the same genes, using iPS
cells as a positive control. Levels of OCT3/4 and NANOG were
higher in DPPSCs than in EBs whereas lineage markers as GATA
4, GATA6 and MIXL1 were higher in EBs (Fig. 3G).
The protein expression profile of DPMSCs (Fig. 4A) was
substantially different from that of DPPSCs. Specifically, levels
of embryonic markers (OCT3/4, NANOG and SSEA4) were very
low, whereas levels of CD73 and STRO1 were high in DPMSCs.
Comparative FACS analysis was carried out on different
passages of populations from both cell types isolated from 14-,
17-, 18-, 28- and 38-year-old donors (supplementary material
Fig. 1. Characterisation and cellular morphology of
pluripotent stem cells obtained from dental pulp (DPPSCs) by
in vitro expansion. (A) Morphology of DPPSCs at different
passages (P5, P10 and P15). (B) Analysis of DPPSC immuno-
phenotype by confocal microscopy shows the expression of
SSEA4 PE (2861.13%) together with OCT3/4 FITC (60.365.3%)
or NANOG FITC (21.3%63.6). Average of three independent
experiments. (C) Cytogenetic analysis of undifferentiated DPPSCs
(P15) show 46 XY without aneuploidy or polyploidy;
chromosome structural abnormalities were not detected. (D) Cells
examined by transmission electron microscopy show large nuclei
and small cytoplasmic volume. Scale bar: 10 mm. (E) Short-CGH
analysis showing genetic stability of DPPSCs from a female
donor (n53).
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Table S2). The two cell types were easily distinguishable by their
morphology. DPMSCs showed the typical flat and elongated
appearance of mesenchymal cells, whereas DPPSCs were smaller
and more spherical in shape (Fig. 4B). Cell diameters ranged
from 8–12 mm for DPPSCs and 12–19 mm for DPMSCs
(Fig. 4C).
Multiscreen-MIC plate carbonate filters were used to evaluate
the migratory capacity of DPPSCs. Although they came from the
same donor and were from the same passage, more DPPSCs
migrated across the filters than DPMSCs (Fig. 4D). To compare
the adhesive ability of DPPSCs and DPMSCs, the expression of
integrin CD29 was evaluated by FACS analysis. The results
showed that 99.6% of DPPSCs expressed integrin CD29,
compared to only 82.3% of DPMSCs (Fig. 4E).
Although they were the main population, DPPSCs coexisted in
culture with other cell types, such as mesenchymal stem cells
from the dental pulp (DPMSCs), due to the lack of a stringent
selection when performing primary culture and successive
cultures with DPPSC medium. The two populations were
indistinguishable from each other by FACS analysis, although
size was known to be different. The percentages of OCT3/4,
NANOG and CD73 in different gates depending on size and
complexity were insufficient to distinguish the two populations as
well (Fig. 4F,G; supplementary material Table S3).
Fig. 2. FACS characterisation, gene
expression of P15 DPPSCs and
teratoma formation. (A) FACS analysis
of P15 DPPSCs for membrane markers:
CD105 (90.7762.28%), CD146
(13.1760.68%), CD45 (0.0260.39%)
and CD34 (0.0660.05); (B) FACS
analysis of P15 DPPSCs for nuclear
markers: STRO1 (4.4261.23), TRA1
(0.0060%), OCT3/4 (62.9865.22%)
and NANOG (22.9662.58%).
(C) Analysis by FACS of DPPSCs with
double staining (19.55%) for OCT3/4
FITC (27.08%) and NANOG PE
(25.9462.51). Expressed as average of
three independent experiments. (D) RT-
PCR of OCT3/4, SOX2, TERT and
GAPDH of DPPSC P15 in 2D culture.
(E) OCT3/4 detection by western blot of
DPPSCs at different passages compared
with DPMSCs. NTERA cells and BM-
MAPCs were used as positive controls,
and Schwann cells and DPMSCs were
used as negative controls.
(F) Transplantation of P15 DPPSCs and
DPMSCs isolated from the same donor
from different ages (14, 17, 28 years old)
into immunodeficient mice resulted in
apparent teratoma-like formation (left
flank) after 5 weeks; DPMSCs P15 were
used as a negative control (right flank).
H&E staining of teratoma-like structures
induced by DPPSCs show the presence
of tissues from mesoderm, endoderm and
ectoderm. (G) H&E staining of teratoma-
like structure after 3 weeks. Circle
highlights zone that is magnified in H–K.
(H) Immunohistochemical staining for
OCT3/4. (I) Immunohistochemical
staining for SSEA4.
(J) Immunohistochemical staining for
NANOG. (K) Immunohistochemical
staining for LIN28.
Immunohistochemical staining shows
embryonic markers SSEA4, LIN28,
OCT3/4 and NANOG (black arrows).
(L) H&E staining showing chondroid
tissue, chondroid matrix, fibroblasts and
collagen fibres. (M) H&E staining
showing gut-like epithelium. (N) H&E
staining showing nerve-like tissue
and keratin.
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To further characterise the two cell populations, we performed
magnetic separation using a human PE selection kit. Cells
positive for CD73 were stained with a PE-conjugated antibody,
and we extracted RNA from both the CD732 and CD73+
populations after separation. RT-PCR was performed to
determine embryonic gene expression. The CD732 population
expressed TERT, OCT3/4 and SOX2, but the CD73+ cells did not
(Fig. 4H). This confirmed our previous assumption that DPPSCs
coexisted with DPMSCs when cultured in vitro.
We also observed a correlation between the embryonic
development stages of the third molar and the percentage of
OCT3/4 and NANOG expression by FACS analysis in pulp
tissues from donors of different nolla stages (6–10) and different
ages on the same day of extraction (n514 samples)
(supplementary material Table S4). To determine the
relationship between specific DPPSCs markers and tooth nolla
stages, the expression profiles were subjected to regression
analysis using nolla stage as the independent variable to
determine the subpopulation of DPPSCs. All the samples
showed the presence of DPPSCs and low expression of the
markers OCT3/4 and NANOG.
To see whether the culture conditions were a key aspect for the
maintenance of the different phenotypes between DPPSCs and
DPMSCs, we cultured each type of cell with the medium of the
other one. After one week changing the medium every 2 or 3
days we observed some phenotypic changes (Fig. 5A). DPPSCs
acquired a longer and flattered shape whereas some of the
DPMSCs became smaller and with a morphology resembling
DPPSCs. Changes were easier to see in DPPSCs culture in
mesenchymal media than in the other way. We checked the
expression of the embryonic markers that differ between the two
cell types. We observed that DPPSCs cultured in mesenchymal
medium lost the expression of NANOG, whereas the OCT3/4
levels only decreased. In the case of DPMSCs cultured in DPPSC
Fig. 3. Generation of DPPSC P15 embryoid bodies. (A) AggreWell system (Stem Cell Technologies), which utilises a micropatterned culture surface and
centrifugal forced aggregation to direct the formation of EBs by DPPSCs for 5 days. Scale bar: 100 mm. (B) Morphology of DPPSC embryoid bodies examined by
light microscope. (C) Alkaline phosphatase staining of DPPSC embryoid bodies. Scale bar: 100 mm. (D) Immuno-phenotype analysis by fluorescence microscopy
shows the expression of OCT3/4 FITC. (E) Immunostaining of DPPSC EBs generated by AggreWell system with NANOG FITC. (F) RT-PCR analysis of OCT3/
4, NANOG, SOX2, SOX1, BDNF, MIXL1, GATA4, GATA6 and GAPDH, comparing expression of hIPSCs, EBs from P15 DPPSCs and P15 DPMSCs and DPPSCs.
(G) qRT-PCR analysis of GATA4, GATA6, MIXL1, NANOG, OCT3/4, SOX1 in DPPSCs P15, EBs from DPPSCs and hiPSC. Expression levels were normalized to
GAPDH. Data represented as means 6 s.d. of three independent experiments.
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medium, cells gained the expression of both OCT3/4 and
NANOG (Fig. 5B).
To confirm the pluripotent capacity of DPPSCs we performed
three in vitro differentiation assays in which DPPSCs were
induced to give rise tissues from all three germ layers.
Mesoderm differentiation
We analysed the ability of DPPSCs to differentiate into osteoblasts
in 2D by immunofluorescence and qRT-PCR. The morphology of
DPPSCs cultured with osteogenic media changed over three weeks
of differentiation, resulting in cells with a bone-like appearance
(Fig. 6A) that expressed the osteoblast marker OSTEOCALCIN
(Fig. 6B). The differentiated cells showed upregulated expression
of specific bone tissue genes, such as ALP, OSTEONECTIN,
OSTECALCIN (Fig. 6C), OSTEOPONTIN, COLLAGEN I,
COLLAGEN III and BMP2, whereas NANOG was downregulated
(supplementary material Table S5). Human bone cDNAs were used
to normalise the data, GAPDH was used as a housekeeping gene
and DPPSC undifferentiated dental pulp cells were used as a
negative control (data not shown). ALP, OSTEONECTIN and
Fig. 4. Comparison of morphology and protein profiles in DPPSCs and DPMSCs. (A) Immuno-phenotype by FACS analysis of P15 DPMSCs isolated from
dental pulp. Expression of STRO-1 (84.1261.67%), NANOG (0.2860.33%), SSEA4 (0.0960.12%), OCT3/4 (0.260.2%), CD73 (7262.69%) is shown as the
average of three independent experiments. (B) Comparison of morphology of DPPSCs and DPMSCs from the same donor and the same passage (P15). (C) Cell
diameters of DPPSCs and DPMSCs measured by Scepter Millipore. (D) Cell migration capacity of P15 DPPSCs and DPMSCs from the same donor and hNTERA
cells, which were used as a positive control, was determined using a Multiscreen-MIC Plate polycarbonate filter (8 mm pore size), incubated at 37 C˚, 5% CO2 for 6
hours. Significance was set at *P#0.05 (n55). (E) Analysis by FACS for CD29 expression in a 3D culture of DPPSCs at P15 (99.660.61%) and DPMSCs at P15
(82.367.88%). (F,G) Analysis of the different populations coexisting in DPPSC cell culture in terms of their cell size (FSC) and their complexity (SSC).
Percentage of OCT3/4+, NANOG+ or CD73+ cells in every gate analysed is shown with respect to the total. (H) RT-PCR for embryonic genes TERT, OCT3/4 and
SOX2 of the two separated cell populations of DPPSC (CD732) and DPMSC (CD73+) cultures.
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OSTEOCALCIN expression increased in the first, second and third
weeks of differentiation. We also observed a decrease in NANOG
expression. To confirm bone-like cell differentiation, we used
Alizarin Red to stain extracellular matrix deposits consisting of
hydroxyapatite, calcium and magnesium salts (Fig. 6D). Taken
together, these assays demonstrate that DPPSCs could efficiently
differentiate into bone-like tissue and express specific bone tissue
genes.
Differentiation was also performed using a Cell Carrier 3D
glass scaffold. When cultured in osteogenic differentiation
medium, DPPSCs derived into bone-like tissue that was able to
synthesise typical bone structures, such as collagen and cortical
structures that were detectable by SEM analysis (Fig. 6E;
supplementary material Fig. S5). The 3D differentiation was
also confirmed by qRT-PCR. During three weeks of
differentiation, ALP, COLLAGEN I and COLLAGEN III
expression steadily increased, whereas the embryonic markers
NANOG and OCT3/4 decreased each week (Fig. 6F). Functional
activity was determined by quantifying ALP activity (Fig. 6G)
and the calcium secretion (Fig. 6H) every week for three weeks.
Both ALP activity and the calcium secretion increased
significantly on days 7, 14 and 21 of osteogenic differentiation.
To demonstrate the capacity of DPPSC to differentiate into
other tissues of the mesoderm cap, we performed a vessel-derived
endothelial cell differentiation, in which DPPSCs were cultured
with basal media (2% FBS, 50 ng/ml VEGF, 10 ng/ml bFGF) for
Fig. 5. Changes in expression of embryonic markers upon changing the
culture conditions. (A) Changes in morphology in DPPSCs and DPMSCs
when they were cultured in the medium of the other cell type for 1 week.
(B) Changes in expression of embryonic markers in P10 DPPSCs and
DPMSCs when cultured in the medium of the other cell type for 1 week
(2 passages). Expression of OCT3/4 and NANOG was analysed by RT-PCR.
Fig. 6. Differentiation of P15 DPPSCs into mesoderm. (A) Cell morphology
during osteogenic 2D differentiation at weeks 1, 2 and 3 (W1, W2 and W3).
(B) Immunofluorescence shows the expression of osteocalcin FITC in the
cytoplasm and cell mask Alexa Fluor W696. (C) ALP, OSTEONECTIN and
OSTEOCALCIN detection by qRT-PCR at different time points during 2D
osteogenic differentiation of DPPSCs (n53, from 14-, 17- and 28-year-old
donors, *P,0.05). The mRNA levels were normalised to GAPDH (a
housekeeping gene). The relative expression was normalised to human cDNAs,
which is normalised to 1. (D) Alizarin Red staining of DPPSCs after 3 weeks of
2D osteogenic differentiation. (E) Scanning electron microscopy image of 3D
differentiation of DPPSCs at P15 using a Cell Carrier 3D glass scaffold for 21
days into mesoderm tissues. Bone-like tissue, collagen (white arrow) and
cortical (green arrow) structures were observed. (F) Analysis of the expression
of ALP, COLLAGEN I, COLLAGEN II, NANOG and OCT3/4 by qRT-PCR
during 3 weeks of 3D differentiation. The mRNA levels were normalised to
GAPDH. The relative expression was normalised to human cDNA from bone
(n53, from 14-, 17- and 28-year-old donors, *P,0.05, **P#0.001), which was
designated as 1. (G) ALP activity at different time points of osteogenic
differentiation in 3D for 21 days. Data are presented as means 6 s.d. (n53).
*P#0.05. (H) Calcium quantification at different time points of osteogenic 3D
differentiation for 21 days. Data are presented as means6 s.d. (n53). *P#0.05.
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three week. We observed an increase in the expression of specific
endothelial genes, such as FLK1 and CD14 (by qRT-PCR) and
FLK1 (by immunofluorescence) (supplementary material Fig. S6).
Endoderm differentiation
Another differentiation assay was performed to induce DPPSCs
to generate cells from the endodermal lineage, specifically
hepatocyte-like cells. DPPSCs cultured in 2D with hepatogenic
media for the three weeks showed altered morphologies, with
some cells adopting a polygonal shape similar to hepatocytes
(Fig. 7A). Expression of the typical hepatic protein albumin
(ALB) was detected by immunofluorescence (Fig. 7B). Using
qRT-PCR, we demonstrated that differentiated cells expressed
the hepatic nuclear factors HNF3b, HNF6 and GATA4 (Fig. 7C).
The expression levels of a-fetoprotein (AFP), ALB, CEBPA and
NANOG were also determined (supplementary material Table
S6). We also observed a decrease in NANOG during the 3 weeks
of differentiation (data not shown). Human liver cDNAs
(Ambion) were used to normalise the data and GAPDH was
used as the housekeeping control (data not shown). The levels of
secreted ALB increased significantly over three weeks of
differentiation (Fig. 7D). These results indicate DPPSCs can
upregulate endoderm markers and differentiate into hepatic-like
cells, both genetically and functionally, upon hepatogenic
induction.
Cell Carrier 3D glass scaffolds were also used to perform the
endoderm differentiation. After 21 days of 3D culture with
hepatogenic media, some hepatic structures were seen by SEM
analysis, including large and small pores with a fenestra-like
appearance, the surfaces of sinusoidal endothelial cells and ultra-
structures of sinusoidal endothelial cells (Fig. 7E; supplementary
material Fig. S7). qRT-PCR was performed to evaluate the
expression of hepatic specific genes ALB, AFP and CYP3A4.
Expression of these markers increased each week, whereas the
embryonic markers NANOG and OCT3/4 expression decreased
(Fig. 7F). Functional activity was determined by quantifying
Fig. 7. Differentiation of P15 DPPSCs into
endoderm. (A) Cell morphology of DPPSCs at
different time points (weeks 1, 2 and 3) during 2D
hepatic differentiation. (B) Immunofluorescence at day
21 of 2D differentiation into hepatocyte-like cells shows
the expression of ALB FITC in the cytoplasm and cell
mask Alexa Fluor W696. (C) qRT-PCR detection of
GATA4, HNF3b and HNF6 in 2D differentiated
DPPSCs (n53, *P,0.05). The mRNA levels were
normalised to GAPDH. The relative expression was
normalised to human cDNAs from liver cells, assigned
as 1. (D) ALB synthesis analysis at different days of 2D
differentiation into hepatocyte-like cells. Data are
presented as mean 6 s.d. (n53 from 14-, 17- and 28-
year-old donors). *P#0.05. (E) Scanning electron
microscope image of 3D endoderm differentiation of
DPPSCs at P15 after 21 days on a Cell Carrier 3D glass
scaffold. Hepatic-like cells with large and small open
pores are observed that have a fenestrated appearance
(white arrow). The ultrastructure of sinusoidal
endothelial cells (green arrow) and the surface of
sinusoidal endothelial cells can also be observed.
(F) qRT-PCR detection of ALB, AFP, CYP3A4,
NANOG and OCT3/4 in DPPSCs differentiated into a
3D hepatic lineage (n53, *P,0.05, **P#0.001). The
mRNA levels were normalised to GAPDH. The relative
expression was normalised to human cDNAs from liver
cells, which were assigned as 1. (G) ALB synthesis
analysis at different days of 3D differentiation into
hepatocyte-like cells. Data are presented as means 6
s.d. (n53). *P#0.05. (H) Cytochrome P450-3A4
Metabolic Activity Assay. Data are presented as means
6 s.d. (n53). *P#0.05.
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ALB secretion (Fig. 7G) and P450 CYP3A4 activity (luciferin-
PFBE) (Fig. 7H). As in 2D differentiation cultures, the levels of
secreted ALB increased over time. The activity of CYP3A4 in
differentiated cells was higher than in undifferentiated control
cells. Both experiments were performed in triplicate.
Ectoderm differentiation
Finally, DPPSCs were able to follow a neuroectodermal
differentiation pathway in 2D cultures. The morphology of
differentiated cells was phenotypically clearly similar to neuronal
cells (Fig. 8A). Immunofluorescence staining showed that
differentiated DPPSCs expressed neuronal tissue-specific proteins
such as NEUN (Fig. 8B), GALC 595 and PSD95 (Fig. 8C). qRT-
PCR analysis showed that expression levels of TAU increased with
time, and that the levels of NURR1 and NESTIN increased during
weeks one and two and then plateaued at week three (Fig. 8D).
GFAP, MBP and SOX1 also increased during the first, second and
third weeks, whereas NANOG expression decreased during
differentiation (supplementary material Table S7). Human brain
cDNA (Ambion) was used to normalise the data and GAPDH was
used as the housekeeping control (data not shown).
Discussion
Several populations of stem cells have been isolated from
different parts of the human tooth and all of them have been
shown to have generic mesenchymal stem cell-like properties
(Laino et al., 2005). These cells express markers associated with
the endothelium and/or the smooth muscle, such as Stromal-
derived factor 1 (STRO1), Vascular cell adhesion molecule 1
(VCAM1), Melanoma-associated antigen MUC18 (MUC18) and
smooth muscle actin (Te´cle`s et al., 2005). Other reports have
described the presence of a lateral population of stem cells in the
dental pulp (Casagrande et al., 2006; Liu et al., 2006; Rizzino,
2009; Sloan and Smith, 2007; Volponi et al., 2010; Zhang et al.,
2006b). However, there has been no previously published
reference to the presence of a population of cells in dental pulp
with the protein profile SSEA4+, OCT3/4+, NANOG+, Nestin+,
SOX2+, LIN28+, CD13+, CD105+, CD342, CD452, CD90low,
CD29+, CD73low, STRO1low and CD1462 (Oda et al., 2010), as
presented in this work. OCT3/4, NANOG and SOX2 are
indispensable for indefinite stem cell division, without affecting
differentiation potential or the capacity for self-renewal. The
functional importance of SOX2 and NANOG genes in altering the
progenitor status has also been clearly demonstrated (Hanna et al.,
2010; Ratajczak et al., 2008; Takahashi and Yamanaka, 2006; Yu
et al., 2007; Zuba-Surma et al., 2009). NANOG has been reported
to be a key gene for maintaining pluripotency, as shown by the
capacity for multilineage differentiation and perpetual self-
renewal of cells expressing this gene. Although DPPSCs share
some features with other populations of stem cells in the tooth,
they differ in other aspects, such as gene expression and
differentiation potential (Hirata et al., 2010) due to their
embryonic-like properties. In this work, we observed the
formation of EB-like structures with characteristics similar to
embryonic stem cells and MAPCs (Braccini et al., 2005;
Verfaillie, 2005).
Both DPMSCs and DPPSCs are obtained from dental pulp
using the same isolation protocol. Distinction of these different
cell populations is dependent on the density at which the cells are
seeded and the culture medium. The use of media that contain
growth factors EGF, PDGF and LIF, allows maintenance of the
pluripotent state of DPPSCs. There has been no other report of
the use of a similar medium to culture stem cells from the dental
pulp, so it seems likely that this media formulation is key for
maintaining DPPSCs with typical stem cell properties. In culture,
however, DPPSCs display heterogeneity that can be explained as
a consequence of their spontaneous differentiation and the lack of
clonality upon their isolation. As previously shown, other stem
cell cultures undergo the same processes; for example, MAPC
cultures are heterogeneous, and two cell populations with
different phenotypes (large and small) coexist in the same
culture (Verfaillie, 2005). Here, we have demonstrated that the
DPPSC population coexists in culture with other cell types, such
as DPMSCs, and that the populations were different from one
another, as they differed in pluripotency gene expression after
magnetic separation by CD73. It seems plausible that both cell
types have a common progenitor, but the relationship between
them is still unclear. The fact that DPPSCs express some
embryonic markers but the other population does not suggests
that these populations may be at a different level of the
differentiation hierarchy, and that DPPSCs may be the
progenitors that gave rise to the other populations. Further
experiments will be needed in order to test this hypothesis.
The third molars are the most common source of dental stem
cells, because wisdom tooth extraction is widely performed and
the teeth are usually considered to be medical waste (Otaki et al.,
2007; Yang et al., 2007). Because the third molar is the last tooth
Fig. 8. Neuroectoderm differentiation of P15 DPPSCs. (A) Image by
optical microscopy of the morphology of cells differentiated into neural-like
cells at different time points (weeks 1, 2 and 3). (B) DPPSCs differentiated
into neural-like cells after 3 weeks showed expression of NEUN FITC and
cell mask Alexa Fluor W696. (C) DPPSCs differentiated to neural-like cells
after 3 weeks showed expression of GALC595 and PSD95. (D) Analysis of
the expression of NURR 1, TAU and NESTIN by qRT-PCR during the three
weeks of differentiation. mRNA levels were normalised to GAPDH. The
relative expression was normalised to human cDNA from brain cells (n53,
from 14,- 17- and 28-year-old donors, *P,0.05), which was designated as 1.
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to develop in humans, it is normally in an early stage of
development and is capable of yielding an optimum quantity of
dental pulp tissue for the isolation of DPSCs (Gandia et al., 2008;
Laino et al., 2006; Leeb et al., 2010; Morsczeck et al., 2009;
Smith et al., 2009; Atari et al., 2011; Zhang et al., 2006a).
Although the percentage of DPPSCs decreases with age, a
population of these cells was always present, even in older
patients. Multipotent cells that have a certain degree of
pluripotency, because they are derived from early embryonic
cells and maintained in the adult stage (Ebert et al., 2009), have
been found in adult tissues, such as very small embryonic-like
(VSEL) stem cells in the bone marrow. These studies, together
with the data shown here, indicate that the dental pulp could be
an important source of cells with pluripotent characteristics. We
speculate that DPPSCs could be derived from residual
undifferentiated cells in the dental pulp. However, this
hypothesis requires further testing. The characteristics unique to
these cells are still under investigation, but the current evidence
opens to the way for future comparative studies of the
regenerative potency of DPPSCs and stem cells from other
sources. In addition, the possibility of freezing these cells
following molar extraction seems feasible, as is currently
performed with cells obtained from the umbilical cord.
In this paper, we have shown that DPPSCs have pluripotent-
like properties that have not been found in cells of any other adult
source to date. The ability to form EB-like or teratoma-like
structures has been thought to be exclusive to ES or iPS cells
(Benton et al., 2009; Maltman and Przyborski, 2010). With this
finding, a new field of investigation can be opened. If one
population of cells found in adult individuals can achieve true
pluripotency, there may be other populations with the same or
similar properties that have yet to be discovered. The relationship
between DPPSCs and iPS cells should also be investigated. The
induction of iPS cells seems to be easier from stem cells than
from differentiated cells (Illich et al., 2011). It could be that a
reprogramming process occurs in DPPSCs, but not in
differentiated dermal fibroblasts. Thus, only DPPSCs could
selectively expand when cultured in DPPSC media, but other
cells from the dental pulp could not undergo the reprogramming
process needed to acquire pluripotency. Importantly, the number
of reprogramming factors needed for induced pluripotency could
be reduced when using DPPSCs. Further studies are needed to
answer these questions.
For therapeutic purposes, the reliability and safety of putative
clinical applications for DPPSCs must be considered, especially
the issue of genetic stability. We have demonstrated that DPPSCs
show no chromosome abnormalities when cultured in vitro, such
that we propose that DPPSCs are safe to use for clinical therapies.
We propose that short-CGH should be used in stem cell research
to determine genetic stability when cells are cultured in vitro,
because s-CGH allows the detection of genetic abnormalities that
could remain hidden with the current protocols, such as
karyotype or FISH techniques. In addition, stem cells for
therapeutic applications must be able to differentiate into
different tissues. As we have shown, DPPSCs are capable of
giving rise to mesodermal, endodermal and ectodermal tissues
that express markers typical of osteoblasts (Atari et al., 2012),
hepatocytes and neurons, respectively, as shown by qRT-PCR
assays, in which all data were normalised to human cDNAs of the
respective tissues. The use of 3D culture systems to carry out
differentiation protocols represents an improved system that
simulates the physiological in vivo environment (Dhawan et al.,
2010; Undale et al., 2009). Based on images obtained by inverted
optical microscopy (2D differentiation) and the pictures taken by
SEM (3D differentiation), we observed tissue-specific structures,
such as collagen fibres and fenestra-like structures, in 3D that
were not seen in 2D.
These cells have properties that are not observed in other cells
obtained from adult tissues, which could open a new range of
possibilities for regenerative medicine. The results presented here
suggest that DPPSCs may be useful for treating various disorders,
such as those related to the loss of bone or some of the proteins
synthesised related with the malfunction of liver cells. Further
investigations are needed to fully characterise these cells.
Materials and Methods
Patient selection
Healthy human third molars extracted for orthodontic and prophylactic reasons
were selected from 20 different patients of different sexes and ages (14–60 years
old). The extraction procedure was kept simple to prevent tooth damage. Dental
pulp tissues used for these experiments were obtained with informed consent from
donors. All experiments were performed in accordance with the guidelines on
human stem cell research issued by the Committee on Bioethics of the
International University of Catalonia.
Primary cells obtained from human molar samples
Immediately after extraction, the third molars were washed using gauze soaked in
70% ethanol, followed by a wash with sterile distilled water. Holding the tooth
with upper incisor forceps, an incision was made between the enamel and the
cement using a cylindrical turbine bur. A fracture was made on the same line, and
fragments of the tooth were placed in a Falcon flask containing sterile 16 PBS.
The samples were rapidly transported to the laboratory and placed in Petri dishes in
a laminar flow hood. Tissues were isolated from the dental pulp using a sterile
nerve-puller file 15 and forceps. Cellular separation was completed by digesting
the divided pulp tissue with collagenase type I (3 mg/ml) (Sigma) for 60 minutes at
37 C˚. Cells were then separated using an insulin syringe and centrifuged for 10
minutes at 275 g (RCF). The cell fraction was washed twice with sterile 16PBS
and centrifuged again for 10 minutes at 275 g at room temperature. Once collected,
the cells were counted and seeded in DPPSC medium. In order to establish the
primary culture, the cells were grown in 96-, 24- and 6-well culture dishes and in
150 ml flasks coated with 100 ng/ml human fibronectin inside a 5% CO2
humidified chamber for 3 weeks. The medium was changed every 4 days. During
the splitting/passaging of DPPSCs, cell density was maintained at 80–100 cells/
cm2 by detaching cells with 0.25% trypsin (Cellgro) and replating every 36–48
hours, when cells were 60% confluent.
DPPSC culture medium
The cell expansion medium consisted of 60% DMEM low glucose (Sigma) and
40% MCDB-201 (Sigma) supplemented with 16 Insulin-Transferrin-Selenium
(ITS) (Sigma), 16linoleic acid bovine serum albumin (LA-BSA) (Sigma), 1029 M
dexamethasone (Sigma), 1024 M ascorbic acid 2-phosphate (Sigma), 100 units of
penicillin, 1000 units of streptomycin (PAA), 2% foetal bovine serum (Sigma),
10 ng/ml hPDGF-BB (R&D Systems), 10 ng/ml EGF (R&D Systems), 1000 units/
ml hLIF (Chemicon), Chemically Defined Lipid Concentrate (Gibco), 0.8 mg/ml
BSA (Sigma) and 55 mM b-mercaptoethanol (b-ME, Sigma).
Base medium
The base medium consisted of 60% DMEM low glucose (Gibco), 40% MCDB-201
(Sigma) with 16 Insulin-Transferrin-Selenium, 16 linoleic acid BSA, 1029 M
dexamethasone (Sigma), 1024 M ascorbic acid 2-phosphate (Sigma), 100 units of
penicillin and 1000 units of streptomycin (Gibco).
Isolation and culture of human dental pulp mesenchymal stem cells
(DPMSCs)
Human adult DPMSCs were isolated from the dental pulp of third molars and were
suspended in Dulbecco’s Modified Eagle’s Medium (DMEM, Biochrom) containing
2 ng/ml basic fibroblast growth factor (bFGF) and 10% foetal bovine serum (FBS,
Hyclone). Cells were plated at a density of 300,000 cells/cm2. The medium was
changed after 72 hours and every 2 days thereafter. To propagate DPMSCs, the cells
were detached at 90% confluence by the addition of phosphate buffered saline (PBS,
Biochrom) containing 0.05% trypsin-ethylenediaminetetraacetic acid (EDTA,
Biochrom) and replated at a density of 4000 cells/cm2.
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Human NTERA-2 and IPS
NTERA-2 cells were obtained from the ATCC. Cells were maintained and cultured
in Dulbecco’s Modified Eagle’s Medium supplemented with 10% foetal bovine
serum and 1% penicillin-streptomycin at 37 C˚ humidified atmosphere at 5% CO2.
hIPS wire was kindly donated by our collaborators at the University of Navarra.
Flow cytometry
FACS analysis was carried out the same day of the extraction and again after two
and three weeks of culture initiation. The following fluorochrome-labelled
monoclonal antibodies were used: CD13 FITC (eBioscience), SSEA4 PE
(eBioscience), OCT3/4 FITC (RD SYSTEMS), CD45 PE-Cy5 (BD
Pharmingen), CD105 FITC (BD Pharmingen), CD34 PE-Cy5 (BD Pharmingen),
CD73 PE (BD Pharmingen), CD146 FITC (BD Pharmingen), CD90 FITC
(eBioscience), CD29 PE (BD Pharmingen), STRO1 FITC (BD Pharmingen),
LIN28, SSEA1 PE, SOX2 PE and NANOG FITC (Abcam). For the analysis of
control samples, different IgG isotypes coupled to FITC, PE and PE-Cy5
fluorochromes (BD Pharmingen) were used. The cell suspension (in PBS plus 2%
FBS) was incubated for 45 minutes at 4 C˚ in the dark. Later, cells were washed
twice with PBS containing 2% FBS and centrifuged for 6 minutes at 275 g (RCF).
Depending on the number, cells were resuspended in 300 to 600 ml of PBS and 2%
FBS. All flow cytometry measurements were made using a FACScan cytometer
(FACSCalibur) and analysed using the winMDI 2.8 program.
Karyotyping
The cells were trypsinised and centrifuged at 250 g (RCF). The cell pellet was
resuspended in a volume less than or equal to 500 ml of DMEM-LG and was then
subjected to a hypotonic shock with 0.075 M KCl that had been pre-heated to 37 C˚
(the saline solution was added drop by drop under continuous agitation). After
30 minutes of incubation in the presence of KCl at 37 C˚, the cells were centrifuged
at 300 g (RCF) for 10 minutes. The nucleus suspension was fixed twice
consecutively in methanol:acetic acid (3:1). After the final centrifugation step, the
final cell pellet was resuspended in fixation liquid and extensions were performed
on glass slides that were pre-cooled to 4 C˚. The extensions were stained using
GIEMSA stain and the number of cells in metaphase was counted using a light
microscope at a 1006 magnification with oil immersion. A minimum of 50
metaphases were counted per sample.
RNA isolation and qRT-PCR
Total cellular RNA samples were extracted using Trizol (Invitrogen) from the
following cell types: DPPSCs at passages 5, 10 and 15 (P5, P10 and P15), H-
NTERA, DPMSCs and differentiated cells. RNA was extracted weekly from the
differentiated cells. Two mg of RNA was treated with DNase I (Invitrogen) and
reverse-transcribed using M-MLV reverse transcriptase (Invitrogen). We analysed
the efficacy of the cDNA (1, 0.1, 0.01, 0.001, 0.0001 dilutions) at different
concentrations for all primers of pluripotent genes using NTERA cells as positive
controls. Additionally, we tested the following samples as positive controls:
hepatocyte markers from human liver cDNA samples, osteoblast markers from
human bone cDNA and neuroectoderm markers from human brain cDNA
(Ambion). Quantitative RT-PCR was performed using the CFX96 thermocycler
(Bio-Rad). Quantitative RT-PCR was performed using 50 ng of cDNA and SYBR
Green Supermix (Bio-Rad Laboratories, Inc.). cDNA samples were amplified
using specific primers with the following conditions for 40 cycles. The expression
levels of genes of interest (supplementary material Table S1) were normalised
against the housekeeping gene GAPDH. The relative expression levels were
normalised to human cDNAs (positive controls), which were assigned as 1. The
results were analysed using the 2DDCt method.
Western blotting
Total protein was extracted from the following samples: DPPSCs collected at
different passages (P5, P10, P15 and P20), DPMSCs, NTERA-2, HEK 293 and
bone marrow derived-MAPCs. Cell lysates with equal protein concentrations
(20 mg/ml) were separated by SDS-PAGE on 12% polyacrylamide gels and
transferred onto nitrocellulose membranes. The membranes were blocked with 1%
(w/v) BSA in PBS containing 0.1% Tween 20, blotted with OCT3/4 and GAPDH
primary antibodies (1:5000) and blotted with secondary antibodies (1:15,000). All
antibodies were purchased from Abcam.
Immunofluorescence analysis
Samples were fixed with 4% paraformaldehyde (Sigma) for 4 minutes at room
temperature followed by methanol (Sigma) for 2 minutes at 220 C˚. For nuclear
ligands, cells were permeabilised with 0.1 M Triton X-100 (Sigma) for 10 minutes.
Slides were incubated sequentially for 30 minutes each with primary antibody and
FITC, PE or PE-Cy5-coupled anti-mouse IgG antibodies. Between each step, the
slides were washed with 1% BSA (Sigma) in PBS. Cells were examined using
confocal fluorescence microscopy (Confocal 1024 microscope, Olympus AX70,
Olympus Optical, Tokyo).
Teratoma formation and histological analysis
Eight-week-old nude mice (Samtako Bio Korea, Seoul, Korea) were anaesthetised
with diethyl ether. Fifty microliters of a P15 DPPSC or DPMSC cell suspension
(46107 cells/ml), from three different donors (14-, 17-, 28-year-old donors), mixed
with 50 ml of Matrigel (BD) was injected subcutaneously into the dorsal flanks of
the mice, which were then housed with free access to water and food under specific
pathogen-free conditions. After 3 or 5 weeks, the teratoma-like structures were
surgically dissected from the mice followed by fixation with 4% paraformaldehyde
and 1.25% glutaraldehyde, and the mice were subjected to histological analysis.
Specimens were embedded in paraffin, cut into 3 mm sections and stained with
haematoxylin and eosin (H&E).
Immunohistochemistry
Samples were cut into 7-mm-thick sections for immunohistochemical staining.
Slides were placed in PBS for 30 minutes to remove gelatin. After being washed
twice with distilled water for 5 min, the sections were blocked against endogenous
peroxidase in 0.3% hydrogen peroxide for 15 minutes and 10% normal goat serum
in PBS for 1 hour at room temperature to reduce nonspecific antibody interactions.
The slides were incubated with mouse monoclonal primary antibodies against
human OCT3/4 (1:400, BD), NANOG (1:400, BD), SSEA4 (1:400, BD) and
LIN28 (1:400, BD) at 4 C˚ overnight. After washing with PBS, the specimens were
incubated with biotinylated goat anti-mouse secondary antibody (Zymed) and
streptavidin peroxidase (Zymed) at room temperature for 10 minutes each. Finally,
the specimens were visualised using a diaminobenzidine reagent kit (Zymed). The
immunostained sections were counterstained with H&E.
Transmission electronic microscopy
A piece of the cell pellet measuring 1 mm3 was fixed in a solution of 2%
formaldehyde, 2.5% glutaraldehyde and Karnoski buffer with cacodylate (0.2 mol/
l, pH 7.4). After 48 hours, the samples were soaked in araldite. The ultra-fine
sections were stained for contrast with citrate and then observed using an
electronic microscope (Zeiss EM900).
Scanning electron microscopy
For SEM analysis, samples were fixed in 2.5% glutaraldehyde (Ted Pella) in 0.1 M
Na-cacodylate buffer (EMS, Electron Microscopy Sciences, Hatfield, PA)
(pH 7.2) for 1 hour on ice. After fixation, the samples were treated with 1%
osmium tetroxide (OsO4) for 1 hour. The samples were dehydrated in serial
solutions of acetone (30–100%) with the scaffolds mounted on aluminium stubs.
The samples were then examined using a Zeiss 940 DSM scanning electron
microscope.
Cell migration assay
The cell migration capacity of DPPSCs and DPMSCs from the same donor, as well
as hNTERA cells, which were used as a positive control, was tested using a
Multiscreen-MIC Plate polycarbonate filter (8 mM pore size) (Millipore).
Approximately 16103 cells in 150 ml were added to the bottom wells of the
filter plate and incubated at 37 C˚ in 5% CO2 for 6 hours. After incubation, the
filters were removed and the topside of the membrane was scraped to remove non-
migrated cells. The filters were then stained with Toluidine Blue. The cells were
counted using a light microscope. Experiments were performed in triplicate and
the data were pooled.
Short-chromosome genomic hybridisation (short-CGH)
DPPSCs were isolated one by one by manual catching and short-CGH technique
was developed (Rius et al., 2010) (n515). Hybridisation of control and DPPSC
samples was carried out against a masculine cell preparation.
Mesoderm differentiation
For bone differentiation, cells were seeded in six-well plates and in a Cell Carrier
3D glass scaffold (Orla protein) on a 24-well plate with culture medium at a
density of 36103 cells P15 per cm2. After 24 hours, differentiation was initiated by
the following medium: a-MEM containing 10% heat inactivated FBS, 10 mM b-
glycerol phosphate (Sigma), 50 mM of L-ascorbic acid (Sigma), 0.01 mM
dexamethasone and 1% penicillin and streptomycin. The medium was changed
every 3 days for 21 days. Differentiated cultures were evaluated by qRT-PCR for
ALP, OSTEONECTIN, OSTEOCALCIN, OSTEOPONTIN, COLLAGEN I,
COLLAGEN III, BMP-2 and NANOG every week. The cultures were also
analysed via immunofluorescence for OSTEOCALCIN and Alizarin Red staining
after 3 weeks of differentiation.
Vessel-derived endothelial cell differentiation
Undifferentiated DPPSCs were cultured at a density of 36103 cells per cm2 with
basal media for 1 day. Culture medium was then exchanged for differentiation
media (Basal Media, FBS 2%, VEGF 50 ng/mL, bFGF 10 ng/ml). Cells were
grown on coverslips and 6-well plates treated with Fibronectin and incubated at
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37 C˚ at 5% CO2. The medium was changed every 3 days for 21 days.
Differentiated cultures were evaluated by qRT-PCR and immunofluorescence.
RNA was obtained at day 0 and then weekly and tested for endothelial gene Flk1
and CD14 expression by qRT-PCR.
Endoderm differentiation
For 2D differentiation, DPPSCs P15 were seeded in 6-well plates with culture
medium at a density of 56104 cells/cm2. The following day, the culture medium
was exchanged for differentiation medium consisting of base medium containing
100 ng/ml HGF and 100 ng/ml FGF-4 (R&D Systems). The medium was changed
every 3 days for 3 weeks. Differentiated cultures were evaluated by qRT-PCR
for GATA4, HNF3b, HNF6, AFP, ALB, CEBPA and NANOG expression.
Differentiated cells were identified using immunofluorescence microscopy for
albumin protein expression and albumin secretion analysis at different days of
differentiation.
For 3D differentiation, 56104 cells P15 were seeded in a Cell Carrier 3D glass
scaffold (Orla protein) pre-coated with 2% Matrigel and placed in 24-well plates
with RPMI medium (Mediatech) supplemented with GlutaMAX and penicillin/
streptomycin and containing 0.5% defined foetal bovine serum (FBS; HyClone)
and 100 ng/ml Activin A (R&D Systems). Three days post-induction, the medium
was refreshed using the same RPMI-based medium with 100 ng/ml Activin A but
replacing FBS by KOSR 2%. After 2 days, definitive endoderm cultures were
refreshed with RPMI medium supplemented with GlutaMAX and penicillin/
streptomycin and containing 2% KOSR, 10 ng/ml FGF-4 (R&D Systems) and
10 ng/ml HGF (R&D Systems). Three days later, the cells were switched to
minimal MDBK-MM medium (Sigma-Aldrich) supplemented with GlutaMAX
and penicillin/streptomycin and containing 0.5 mg/ml bovine serum albumin
(BSA) (Sigma-Aldrich), 10 ng/ml FGF-4 and 10 ng/ml HGF. After another 3 days,
the cells were switched to complete hepatocyte culture medium (HCM)
supplemented with SingleQuots (Lonza) and containing 10 ng/ml FGF-4, 10 ng/
ml HGF, 10 ng/ml oncostatin M (R&D Systems) and 1027 M dexamethasone
(Sigma-Aldrich). Differentiation was continued for another 9 days. At each stage,
the medium was refreshed every 2–3 days.
Neuroectoderm differentiation
For neural differentiation, cells P15 were seeded in 6-well plates and in 75 cm2
flasks in base culture medium at a density of 36103/cm2. The following day, the
culture medium was exchanged for differentiation medium; the differentiation
medium differed from week to week. During the first week, the medium consisted
of base medium and bFGF (100 ng/ml). During the second week, the medium
consisted of base medium, FGF-8 (10 ng/ml) and SHH (100 ng/ml). During the
third week, the medium consisted of base medium, BDNF (10 ng/ml) and GDNF
(10 ng/ml) + N2 (R&D Systems). The medium was changed every 3 days. Neural
differentiation was evaluated via qRT-PCR for TAU, NURR1, NESTIN, GFAP,
MBP, SOX1 and NANOG expression. Cultures were also analysed by
immunofluorescence for PSD95-FITC and GALC-595 protein expression.
Alizarin Red staining
Cells were fixed in a 2.5% glutaraldehyde mixture that was freshly prepared in 16
PBS buffer for 10–15 minutes at room temperature. Cells were then washed with
16 PBS and 2% Alizarin Red solution (Millipore) was added to the fixed cells.
Following incubation at 37 C˚ for 20 minutes, cells were then observed through
microphotography (positively stained nodules are in orange-red).
Albumin secretion
The production of albumin was determined using the Albumin Assay Kit (Sigma)
according to the manufacturer’s instructions.
Alkaline phosphatase staining
For alkaline phosphatase (ALP) staining, EBs were fixed in a solution of 4%
paraformaldehyde in PBS for 20 minutes. After extensive washing in PBS, cells
were incubated in NTMT solution [10 mM NaCl, 100 mM Tris-HCl (pH 9),
50 mM MgCl2, supplemented with 0.1% Tween-20] for 5 minutes and then in
NTMT solution supplemented with NBT (Nitro-Blue Tetrazolium Chloride) and
BCIP (5-Bromo-4-Chloro-39-Indolyphosphate p-Toluidine Salt) in darkness until
the staining developed.
ALP activity
During the 3D osteoblast differentiation of DPPSCs and from passage number 15,
ALP activity was quantified every week by spectrophotometry using a Cromatest
kit (Linear), in accordance with the manufacturer’s instructions. We measured the
absorbance of each sample at 1, 2, 3, 5 and 10 minutes.
Calcium quantification
Differentiated cells were washed twice with 16 PBS. Accumulated calcium was
removed from the cellular components using lysis solutions contained in the Sigma
kit for the analysis of calcium accumulation, according to the manufacturer’s
instructions. The total calcium was calculated using standard solutions and the
absorbance was measured at 575 nm.
Cytochrome P450 3A4 metabolic activity assay
Cytochrome P450 (CYP) 3A4 enzyme activity assay was assessed by measurement
of luciferase activity with the P450-Glo CYP3A4 assay, according to the
manufacturer’s instructions. Differentiated cells were incubated at 37 C˚ in DMSO
plus ethanol supplemented with 50 mmol/l luciferin PFBE (150 ml/well) and
without DMSO; undifferentiated DPPSCs were used as negative control. After 3
hours of incubation, 50 ml of medium was transferred in a 48-well plate and mixed
with 50 ml of luciferin detection reagent to initiate luminescent reaction. After
20 minutes of incubation at room temperature, luminescence was measured with a
Victor3 luminometer (PerkinElmer).
Statistical analysis
To assess the percentages of specific markers for DPPSCs, data were subjected to a
regression analysis, which considered the independent variable (age) and the
dependent variable (different markers). We established statistical significance at a
P value less than 0.1 (90% confidence level). For all other data, the statistical test
applied was the paired samples t-test, with statistical significance set at P,0.05.
Data were analysed with SPSS Version 16.0 software. The values are expressed as
the mean 6 s.d.
Ethical regulations
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